C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/34 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2565676
The present invention relates to the use of an inhibitor of the expression or activity of the GM3 synthase gene for the treatment of microvascular complications of diabetes, and to a method of screening compounds useful in the treatment and/or prevention of these complications.
La présente invention concerne l'utilisation d'un inhibiteur de l'expression ou de l'activité du gène de la GM3 synthase pour le traitement de complications microvasculaires du diabète; et une méthode de criblage de composés utiles dans le traitement et/ou la prévention de ces complications.
Elbawab Samer
Lagarde Michel
Masson Elodie
Ruggiero Daniel
Troncy Lysiane
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Gm3 synthase as a therapeutic target in microvascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gm3 synthase as a therapeutic target in microvascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gm3 synthase as a therapeutic target in microvascular... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1969101